PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

B Medical Systems has received the worlds-first PQS prequalification from the World Health Organization (WHO) for its U201 Ultra-Low Freezer

Ultra-Low Freezers are used for storing temperature-sensitive specimens, biosamples and vaccines at temperatures as low as -86°C to enable their long-term and reliable storage. The WHO Performance, Quality, and Safety (PQS) process prequalify products and devices so that member states and UN purchasing agencies are assured of their suitability for use in immunization programs.

B Medical Systems developed the U201 Ultra-Low Freezer in response to the growing demand for ultra-low temperature storage of COVID-19 vaccines.

Commenting on the world-first, Luc Provost, CEO of B Medical Systems, said: “WHO PQS prequalification is a testament to the quality and standard of our product.  The U201 Ultra-Low Freezer can work at ambient temperatures as high as 43°C, which means it’s ideal for use in tropical climates. We developed this product as a pandemic response however, with the growth of mRNA technology, such as cell and gene therapy, we see more and more requirements for reliable ultra-low temperature storage across the world.”

The U201 has a gross storage volume of 214L and provides a storage temperature varying from -86°C to -20°C. Designed with state-of-the-art refrigeration technology, it offers superior temperature uniformity and holdover time. It uses a green refrigerant that has minimal impact on the environment and is compliant with the US SNAP and EU F-Gas regulations and offers advanced inbuilt alarm systems and provides 24/7 real-time monitoring solutions via the company’s Real-Time Monitoring Devices (RTMD) and °B Connected solution. The password-protected/NFC-based locking mechanism further prevents unauthorized access to the specimens. The product is certified to operate at ambient temperature as high as +43°C and is an ideal solution for last-mile vaccination campaigns, doctor’s clinics, hospitals and laboratories.  The U201 is also a class II(a)/II certified medical device as per EU MDR and US FDA regulation.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026